glp-1 drugs moa Receptor Agonists as Treatments for Type 2 Diabetes Graphical presentation of the mechanism

Editorial Advisory Board Member, Harvard Health Publishing GLP-1 drugs for diabetes and weight loss have proven to be very effective, but they do have side effects

[DOI] [PubMed] [Google Scholar] 81.Serrano D

Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

20200112) and Natural Science Foundation of Shanxi Province (No

Did the authors limit the types of persons with Parkinsons disease who were allowed to enroll in the trial